Heterogeneity-based stratification identifies CKMT2 as a prognostic marker in osteosarcoma.
Saved in:
| Title: | Heterogeneity-based stratification identifies CKMT2 as a prognostic marker in osteosarcoma. |
|---|---|
| Authors: | Li X; Department of Pediatric Oncology, Shandong Cancer Hospital and Institute, Jinan, Shandong, China., Li G; Department of Urology, Shandong Cancer Hospital and Institute, Jinan, China., Peng T; Department of Spine, East Hospital, Tongji University School of Medicine, Shanghai, China., Qiu J; Department of Orthopedic Surgery, Institute of Digital Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China., Li S; Department of Interventional Radiology, Shandong Cancer Hospital and Institute, Jinan, Shandong, China., Wang J; Department of Pediatric Oncology, Shandong Cancer Hospital and Institute, Jinan, Shandong, China., Zhang J; Department of Orthopedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China. |
| Source: | Frontiers in cell and developmental biology [Front Cell Dev Biol] 2026 May 25; Vol. 14, pp. 1822741. Date of Electronic Publication: 2026 May 25 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2296-634X |
|---|---|
| DOI: | 10.3389/fcell.2026.1822741 |
